高级检索
当前位置: 首页 > 详情页

A multicenter, retrospective study analysis: Evaluating the efficacy and safety of pembrolizumab in the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma

| 认领 | 导出 |

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE ◇ CPCI(ISTP)

机构: [1]Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China [2]Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China [3]Department of Radiation Oncology, Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China [4]Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China [5]Department of Radiation Oncology, The First Affiliated Hospital of University of Science and Technology of China, Hefei, China [6]Department of Oncology, Xiangya Hospital, Central South University, Changsha, China [7]Department of Radiation Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, China [8]Department of Oral and Maxillofacial Surgery, Affiliated Hospital of Qingdao University, Qingdao, China [9]Department of Head and Neck Radiotherapy, Cancer hospital of Dalian university of technology, Liaoning cancer hospital & institute, Shenyang, China [10]Cancer Center, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China [11]Department of Radiation Oncology, The First Hospital of China Medical University, Shenyang, China [12]Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China [13]Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China [14]Department of Otorhinolaryngology, Head and Neck Surgery, Yuhuangding Hospital, Qingdao University, Yantai, China [15]Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China [16]Department of Radiation Oncology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China [17]Department of Head and Neck Cancer Radiotherapy, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, China
出处:
ISSN:
语种:
WOS:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 1 区 医学
小类 | 1 区 肿瘤学
最新[2023]版:
大类 | 1 区 医学
小类 | 1 区 肿瘤学
JCR分区:
出版当年[2023]版:
Q1 ONCOLOGY
最新[2023]版:
Q1 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2023版]

第一作者:
第一作者机构: [1]Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43377 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号